Congress trades
Elevance Health Inc. (ANTM)
About Elevance Health Inc.
from the company's filings and listing- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- Chief executive
- Gail Boudreaux
- Employees
- 98,200
- Listed since
- Oct 30, 2001
- Market value
- $114.6B
- Price to earnings
- 2.1
- Earnings per share
- $20.55
- Dividend yield
- 1.42%
Earnings
6 reported quarters| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2022reported Jul 20, 2022 | $6.78 | $7.72 | $38.6B | $38.1B | EPS missRevenue in line |
| Q1 FY2022reported Apr 20, 2022 | $8.25 | $7.81 | $38.1B | $35.9B | EPS beatRevenue beat |
| Jan 26, 2022 | $5.14 | $5.11 | $36.6B | $37.3B | EPS in lineRevenue miss |
| Q3 FY2021reported Oct 20, 2021 | $6.79 | $6.37 | $35.8B | $35.3B | EPS beatRevenue in line |
| Q2 FY2021reported Jul 21, 2021 | $7.03 | $6.33 | $33.9B | $35.3B | EPS beatRevenue miss |
| Q1 FY2021reported Apr 21, 2021 | $7.01 | $6.51 | $32.4B | $29.9B | EPS beatRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in ANTM
20 disclosures of 51 on record · median 25d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Michael T. McCaulFiled late | Stock | Sale | $15,001 - $50,000 | n/a | Jul 1, 2022 | Aug 17, 2022 | 47d |
| Michael T. McCaulFiled late | Stock | Sale | $50,001 - $100,000 | n/a | Jul 1, 2022 | Aug 17, 2022 | 47d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +6.1%S&P +6.4% · vs S&P 500 -0.3% | Jun 16, 2022 | Jul 7, 2022 | 21d |
| Diana Harshbarger | Stock | Sale | $1,001 - $15,000 | -2.5%S&P -1.7% · vs S&P 500 -0.8% | May 23, 2022 | Jun 29, 2022 | 37d |
| Michael T. McCaul | Stock | Sale | $100,001 - $250,000 | -4.4%S&P -5.1% · vs S&P 500 +0.8% | May 6, 2022 | Jun 14, 2022 | 39d |
| Michael T. McCaul | Stock | Sale | $50,001 - $100,000 | -5.8%S&P -3.7% · vs S&P 500 -2.1% | May 26, 2022 | Jun 14, 2022 | 19d |
| Michael T. McCaul | Stock | Sale | $100,001 - $250,000 | -5.8%S&P -3.7% · vs S&P 500 -2.1% | May 26, 2022 | Jun 14, 2022 | 19d |
| Diana Harshbarger | Stock | Sale | $1,001 - $15,000 | -2.1%S&P +0.2% · vs S&P 500 -2.3% | May 20, 2022 | May 26, 2022 | 6d |
| John R. CurtisJoint | Stock | Sale | $1,001 - $15,000 | +3.7%S&P -8.7% · vs S&P 500 +12.4% | Mar 9, 2022 | Mar 23, 2022 | 14d |
| John R. CurtisJoint | Stock | Purchase | $1,001 - $15,000 | +6.7%S&P -16.0% · vs S&P 500 +22.8% | Jan 14, 2022 | Feb 2, 2022 | 19d |
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | +8.8%S&P -17.1% · vs S&P 500 +25.9% | Dec 15, 2021 | Jan 27, 2022 | 43d |
| Michael T. McCaul | Stock | Purchase | $50,001 - $100,000 | +22.7%S&P -7.2% · vs S&P 500 +29.9% | Jun 2, 2021 | Jul 16, 2021 | 44d |
| John R. Curtis | Stock | Purchase | $1,001 - $15,000 | +27.3%S&P -8.1% · vs S&P 500 +35.4% | Jun 22, 2021 | Jul 6, 2021 | 14d |
| Sara JacobsFiled late | Stock | Sale | $50,001 - $100,000 | +33.7%S&P -5.2% · vs S&P 500 +38.9% | Apr 9, 2021 | May 28, 2021 | 49d |
| Robert J. Wittman | Stock | Purchase | $1,001 - $15,000 | +62.6%S&P +12.4% · vs S&P 500 +50.1% | Oct 16, 2020 | Nov 19, 2020 | 34d |
| Michael T. McCaul | Stock | Purchase | $50,001 - $100,000 | +70.9%S&P +15.9% · vs S&P 500 +55.1% | Aug 13, 2020 | Sep 22, 2020 | 40d |
| Joe CourtneySpouse | Stock | Sale | $1,001 - $15,000 | +74.4%S&P +16.7% · vs S&P 500 +57.7% | Aug 7, 2020 | Aug 27, 2020 | 20d |
| Ro Khanna | Stock | Sale | $15,001 - $50,000 | +78.8%S&P +20.9% · vs S&P 500 +57.9% | Jul 23, 2020 | Aug 17, 2020 | 25d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +82.0%S&P +21.5% · vs S&P 500 +60.4% | Jul 28, 2020 | Aug 17, 2020 | 20d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +71.4%S&P +20.1% · vs S&P 500 +51.3% | Jul 29, 2020 | Aug 17, 2020 | 19d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 6, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Questions
Which members of Congress have traded ANTM?
Michael T. McCaul, Ro Khanna, Diana Harshbarger, John R. Curtis, Sara Jacobs, Robert J. Wittman and others disclosed ANTM transactions in the filings shown here.
How quickly are ANTM trades disclosed?
Congressional disclosures took a median of 25 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.